Negative regulation of TLR signaling in myeloid cells—implications for autoimmune diseases
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Summary: Toll‐like receptors (TLR) are transmembrane pattern recognition receptors that recognize microbial ligands and signal for production of inflammatory cytokines and type I interferon in macrophages and dendritic cells (DC). Whereas TLR‐induced inflammatory mediators are required for pathogen clearance, many are toxic to the host and can cause pathological inflammation when over‐produced. This is demonstrated by the role of TLR‐induced cytokines in autoimmune diseases, such as rheumatoid arthritis, inflammatory bowel disease, and systemic lupus erythematosus. Because of the potent effects of TLR‐induced cytokines, we have diverse mechanisms to dampen TLR signaling. Here, we highlight three pathways that participate in inhibition of TLR responses in macrophages and DC, and their implications in autoimmunity; A20, encoded by the TNFAIP 3 gene, Lyp encoded by the PTPN 22 gene, and the BCAP/PI 3K pathway. We present new findings that Lyp promotes TLR responses in primary human monocytes and that the autoimmunity risk Lyp620W variant is more effective at promoting TLR‐induced interleukin‐6 than the non‐risk Lyp620R protein. This suggests that Lyp serves to downregulate a TLR inhibitory pathway in monocytes, and we propose that Lyp inhibits the TREM 2/DAP 12 inhibitory pathway. Overall, these pathways demonstrate distinct mechanisms of negative regulation of TLR responses, and all impact autoimmune disease pathogenesis and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621 · cited 2×
“The SH2-dependent binding to p-YxxM within proteins causes a conformational change in the p85 subunit, resulting in increased catalytic activity of the associated p110 protein, and recruitment of the PI3K complex to the plasma membrane where it can access its substrate PI(4,5)P2 resulting in PI(3,4,5)P3 production (76…”
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330 · cited 1×
“The catalytic p110 subunit and regulatory p85 subunit are constitutively found in the cytoplasm in an inactive PI3K complex (75).”
Negative regulation of Toll-like receptor-mediated immune responses
Liew, F. Y., Xu, D., Brint, E. K., & O'Neill, L. A. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1630 · Cited by 1,509 · cited 2×
“As several reviews have covered TLR-negative regulators in a broad manner (30, 31), here, we will focus on three specific negative regulatory pathways that fall in several of these classes, and their implications for autoimmune disease.”
Failure to Regulate TNF-Induced NF-κB and Cell Death Responses in A20-Deficient Mice
Lee, E. G., Boone, D. L., Chai, S., Libby, S. L., Chien, M., Lodolce, J. P., & Ma, A. (2000) · Science · doi:10.1126/science.289.5488.2350 · Cited by 1,409 · cited 1×
“A20 deficiency in all cells leads to a fatal inflammatory disease causing perinatal lethality that does not depend upon the presence of B or T cells, highlighting the potency of A20 as an inhibitor of inflammation in the non-lymphoid compartment(37).”
The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response
Weichhart, T., Costantino, G., Poglitsch, M., Rosner, M., Zeyda, M., Stuhlmeier, K. M., Kolbe, T., Stulnig, T. M., Hörl, W. H., Hengstschläger, M., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.012 · Cited by 801 · cited 1×
“Several studies have shown that PI3K pathway-mediated activation of the mTOR complex promoted IL-10 secretion in response to LPS, and identified the mTORC2 complex that includes Rictor as specifically regulated by PI3K (88, 90, 92).”
Guha, M., & Mackman, N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203298200 · Cited by 799
The Kinase Akt1 Controls Macrophage Response to Lipopolysaccharide by Regulating MicroRNAs
Androulidaki, A., Iliopoulos, D., Arranz, A., Doxaki, C., Schworer, S., Zacharioudaki, V., Margioris, A. N., Tsichlis, P. N., & Tsatsanis, C. (2009) · Immunity · doi:10.1016/j.immuni.2009.06.024 · Cited by 581
Nucleic acid recognition by the innate immune system
Barbalat, R., Ewald, S. E., Mouchess, M. L., & Barton, G. M. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101340 · Cited by 577 · cited 5×
“Therefore, BCAP may function to bring the active p85/p110 complex to the membrane where it can access its substrate PI(4,5)P2, thereby generating PI(3,4,5)P3 that can recruit and activate PDK-1 initiating the PI3K signaling cascade.”
InfluentialAbdollahi-Roodsaz, S., Joosten, L. A. B., Koenders, M. I., Devesa, I., Roelofs, M. F., Radstake, T. R. D. J., Heuvelmans-Jacobs, M., Akira, S., Nicklin, M. J. H., Ribeiro-Dias, F., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32639 · Cited by 527 · cited 1×
“Surprisingly, TLR2 deficiency exacerbated disease due to effects on regulatory T cells in this model (27).”
Hamerman, J. A., Jarjoura, J. R., Humphrey, M. B., Nakamura, M. C., Seaman, W. E., & Lanier, L. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2051 · Cited by 440 · cited 1×
“TREM2/ DAP12 signaling can inhibit not only TLR signaling but also FcR signaling in macrophage (64).”
Self-citationTLR4/MyD88/PI3K interactions regulate TLR4 signaling.
Laird, M. H. W., Rhee, S. H., Perkins, D. J., Medvedev, A. E., Piao, W., Fenton, M. J., & Vogel, S. N. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1208763 · Cited by 342
Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus
Adrianto, I., Wen, F., Templeton, A., Wiley, G., King, J. B., Lessard, C. J., Bates, J. S., Hu, Y., Kelly, J. A., Kaufman, K. M., et al. (2011) · Nature Genetics · doi:10.1038/ng.766 · Cited by 279
Ito, H., & Hamerman, J. A. (2012) · European Journal of Immunology · doi:10.1002/eji.201141679 · Cited by 173
Self-citationRhee, S. H., Kim, H., Moyer, M. P., & Pothoulakis, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513861200 · Cited by 103
Stanford, S. M., Krishnamurthy, D., Falk, M. D., Messina, R., Debnath, B., Li, S., Liu, T., Kazemi, R., Dahl, R., He, Y., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101202j · Cited by 59 · cited 1×
“For these experiments, we purified CD14 monocytes from PBMC of healthy subjects using magnetic bead enrichment, rested the cells for 2 h, treated with either of two Lyp inhibitors (IC11 or 8b) or vehicle control, and then activated with LPS and measured TNF and IL-6 secretion after overnight culture (67, 68).”
Self-citation
Cited by
Filipello, F., Morini, R., Corradini, I., Zerbi, V., Canzi, A., Michalski, B., Erreni, M., Markicevic, M., Starvaggi-Cucuzza, C., Otero, K., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.016 · Cited by 695
“, 2009), TREM2 is recognized to have anti-inflammatory properties on macrophages activated in vitro by Toll-like receptor (TLR) ligands (Hamerman et al., 2016; Turnbull et al., 2006).”
BackgroundConstitutive immune mechanisms: mediators of host defence and immune regulation
Paludan, S. R., Pradeu, T., Masters, S. L., & Mogensen, T. H. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-0391-5 · Cited by 362
Gong, S., Yan, Z., Liu, Z., Niu, M., Fang, H., Li, N., Huang, C., Li, L., Chen, G., Luo, H., et al. (2019) · Hepatology · doi:10.1002/hep.30361 · Cited by 188
Innate Immune Regulations and Liver Ischemia-Reperfusion Injury
Lu, L., Zhou, H., Ni, M., Wang, X., Busuttil, R., Kupiec-Weglinski, J., & Zhai, Y. (2016) · Transplantation · doi:10.1097/tp.0000000000001411 · Cited by 173
Self-citationSong, F., Yi, Y., Li, C., Hu, Y., Wang, J., Smith, D. E., & Jiang, H. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0809-1 · Cited by 63
Metadata
- Authors
- Hamerman, J. A., Pottle, J., Ni, M., He, Y., Zhang, Z., & Buckner, J. H.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2015-12-19
- Volume
- 269
- Issue
- 1
- Pages
- 212-227
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W2221307589
- Cited by
- 109
- References
- 16
- FWCI
- 0.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.